LFG
DNA icon

Larson Financial Group’s Ginkgo Bioworks DNA Stock Holding History

Larson Financial Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-181
Closed -$2.64K – 3512
2025
Q3 		$2.64K Buy
181
+175
+2,917% +$2.09K ﹤0.01% 2596
2025
Q2 		$68 Hold
6
– – ﹤0.01% 3208
2025
Q1 		$34 Hold
6
– – ﹤0.01% 3014
2024
Q4 		$59 Sell
6
-75
-93% -$643 ﹤0.01% 2679
2024
Q3 		$660 Buy
81
+25
+45% +$251 ﹤0.01% 2069
2024
Q2 		$752 Hold
56
– – ﹤0.01% 1765
2024
Q1 		$2.61K Hold
56
– – ﹤0.01% 1321
2023
Q4 		$3.8K Buy
56
+50
+833% +$3.06K ﹤0.01% 1252
2023
Q3 		$453 Buy
+6
New +$480 ﹤0.01% 1583

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Larson Financial Group's DNA Position: Q4 2025 in Review

Larson Financial Group sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 181 shares — an estimated $2.64K sold.

Larson Financial Group first reported a position in DNA in Q3 2023 and held it in 9 quarters. The position peaked at $3.8K in Q4 2023. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Larson Financial Group reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Larson Financial Group sold 181 Ginkgo Bioworks shares in Q4 2025, an estimated $2.64K.
  • Larson Financial Group first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 9 quarters.
  • Larson Financial Group's Ginkgo Bioworks position peaked at $3.8K in Q4 2023.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Larson Financial Group's 13F filing for Q4 2025, filed 6 Feb 2026.